APLS — APELLIS PHARMACEUTICALS INC

Ownership history in XTX Topco Ltd  ·  6 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.12% (2022 Q1)
Avg. % of fund
0.05%
First filed
2022 Q1
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 14,407 +4,622 +47.2% 0.02% $326K $22.63
2024 Q4 ADDED 9,785 +2,649 +37.1% 0.03% $312K $31.91
2024 Q3 ADDED 7,136 +1,696 +31.2% 0.01% $206K $28.84
2024 Q1 REDUCED 5,440 -7,356 -57.5% 0.04% $320K $58.78
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APLS price (monthly, adj. close)

Other funds also holding APLS

As of 2025 Q4 — sorted by position size

Deep Track Capital, LP 3Y 3.47% Avoro Capital Advisors LLC 3Y 7Y 3.02% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.13% Siren, L.L.C. 1.93% RTW INVESTMENTS, LP 3Y 7Y 1.93% Exome Asset Management LLC 1.63% Logos Global Management LP 3Y 1.52% Kynam Capital Management, LP 3Y 1.46% ORBIMED ADVISORS LLC 3Y 7Y 1.25% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.22%
← Back to XTX Topco Ltd Holdings